GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Omed VICA · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 4 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2021

Revenue

$3.3m

FY2014FY2021

Net income

−$879,207

FY2014FY2021

Free cash flow

−$9.7m

FY2014FY2021

Shareholders' equity

$4.0m

FY2014FY2021

Income statement

Fiscal years

FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue$3.3m—$55,521$412,682$355,736$687,448$60,121$27,068
Research and development——$127,266$278,708$1.3m$340,782$5.3m$2.7m
Operating income−$868,250−$60,680−$1.2m−$4.2m−$2.9m−$1.6m−$7.3m−$3.3m
Net income−$879,207−$84,978−$1.2m−$5.8m−$3.0m−$1.6m−$9.4m−$19.0m
Diluted earnings per share-0.01-0.00-0.08-0.38-0.28-0.17-0.99-6.06

Balance sheet

At each fiscal year end

FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Total assets$7.7m$191,536$240,670$298,660$649,831$319,290$447,409$566,666
Cash and short-term investments$15,854$1,517$3,749$18,827$352,498$2,492$9,579$408,252
Total liabilities$3.7m$1.1m$1.5m$792,885$1.6m$1.4m$1.7m$586,971
Debt$333,069$690,787$690,464$79,091$47,921$383,164$813,015$389,424
Shareholders' equity$4.0m−$868,912−$1.2m−$494,225−$911,079−$1.1m−$1.2m−$20,305
Shares outstanding122m122m16m15m11m10m10m3m

Cash flow

Fiscal years

FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations−$1.7m−$429,261−$1.1m−$918,188−$739,598−$427,272−$1.1m−$475,814
Capital spending−$8.0m————−$17,016−$274,470−$116,124
Free cash flow−$9.7m−$429,261−$1.1m−$918,188−$739,598−$444,288−$1.4m−$591,938

Latest quarters

By quarter end

Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Mar 2019Dec 2018Sept 2018
Revenue——$2.0m$1.2m—$54,248$87,426$91,173
Operating income−$640−$640−$373,720$14,040−$507,920−$619,200−$2.6m−$377,505
Net income−$2,067−$1,943−$343,799−$17,685−$515,780−$621,583−$2.6m−$382,786
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.04-0.17-0.02
Capital spending—−$8.0m——————
Total assets$7.7m$7.7m$7.7m$7.1m$194,988$301,882$298,660$319,286
Cash and short-term investments$15,854$15,854$15,854$16,236$15,162$17,258$18,827$29,713
Debt————$622,292$172,382$79,091$80,510
Shareholders' equity$4.0m$4.0m$4.0m$3.1m−$913,076−$588,237−$494,225−$368,327

Valuation history

At each fiscal year end

FY2020
Price to earnings-0.0

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return1067%0%760%-78%-33%90535%46%73%-33%14%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 20-to-1 reverse split · 9 Jul 2018
  • 7-for-1 split · 7 Aug 2015

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.